The ChEMBL-og

I rediscovered a cool app for the Mac recently - Delicious Library 2 , and following some of our books going 'missing', I'm adding my book collection to a on-line library . At the moment, I've done most of the computing books.

We'll be running a ChEMBL database schema walkthrough at 3pm GMT on Thursday 27th January. There will be some changes to the existing schema in the forthcoming ChEMBL_09 release, to allow us to incorporate a lot more information about approved drugs. Therefore this webinar may be of interest not just to new users, wishing to understand the schema/data model, but also existing users who want more information about the changes. We will use webhuddle for the meeting. You don't need an account or any software, just a Java enabled web-browser. There will also be a separate number to dial into the audio. Please click here to sign up for meeting details.

Following planned downtime, the ChEMBL database , and other ChEMBL resources are now back online.

We are attending the ISCB ASBCB Meeting in Cape Town, South Africa from 9th to 11th March 2011. If you are interested meeting up, or in hearing about ChEMBL, getting a demo, asking questions, etc . mail us .

ChEMBL resources will be down due to essential scheduled maintenance from 16.30 GMT on Friday, 7th January 2011 to 21.00 GMT Sunday, 9th January 2011. This will affect all EBI services.

We are speaking at a training school on the prioritisation of drug targets for neglected diseases running from May 16th to May 21st 2011, held at the University of Siena, Italy. It is organised under Working Group 1 of COST Action CM0801. Here is some text from the course brochure (which can be found here ) This training school was conceived to teach and train researchers on the currently available tools that may lead to drug target identification and prioritization, before moving to their validation in vivo . The course will consist of lectures and practical classes. In guided hands-on computer sessions all participants will analyze sequence, structure, and function of unknown sequences. By that they will learn about the existence as well as the source and availability of bioinformatics software and how to apply these tools and interpret results with confidence. The school will provide computers to all trainees. All lectures will be in English. Spaces are limited, and the deadli...

ATC code : G03AB08 and G03FA15 (as combinations) On May 6th 2010, the FDA approved Dienogest, as a component of the oral contraceptive drug Natazia (tradename: Natazia , tradename: Qlaira ). Dienogest (research code:STS-557) is a progestin is a synthetic analog of the natural product progesterone . Dienogest is one of two active components within Natazia, the other being the 17ß-estradiol prodrug - estrogen valerate; Natazia is therefore a Combination Oral Contraceptive (or COC ). Natazia is the first four-phase combined oral contraceptive marketed in the United States - the four phases refering to the differential dosing of the estrogen/progestin throughout the menstrual cycle . Each monthly pack of Natazia contains pills to be taken in a specific order: 2 dark yellow tablets each containing 3 mg estradiol valerate; then 5 medium red tablets each containing 2 mg estradiol valerate and 2 mg dienogest; then 17 light yellow tablets each containing 2 mg estradiol valerate and...